Bryan O’Donnell, Head of Quality at Gaelic Laboratories, explains how to navigate GMP challenges to ensure your company ...

Gil Roth, President of the Pharma & Biopharma Outsourcing Association, shared his insights in the CPHI Annual Report 2024, ...

Entering 2025, the CDMO industry is at a crossroads. Reflecting on conversations over the past year—with CEOs navigating ...

According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

Viracta Therapeutics, Inc., a clinical-stage precision oncology company dedicated to treating and preventing virus-associated ...

Pharmapack Europe has announced the winners of its newly reformatted Pharmapack Awards, recognizing excellence in six key ...

Eleva, a pioneer in unlocking biologics based on a breakthrough manufacturing platform, and 3PBIOVIAN, a contract development ...

The Chan Zuckerberg Initiative (CZI), in collaboration with partners 10x Genomics, Ultima Genomics, and a group of leading ...

PacBio, a developer of high-quality, accurate sequencing solutions, has appointed David Ruggiero as the company’s new Global ...

Independent research institute BioMed X has completed its oncology research project in partnership with Merck, the data from ...

Global oncology portfolio sales were $1.7 billion, up 12%. Imbruvica sales were $848 million, down 6%. Venclexta sales were $655 million, up 11%. Elahere revenues were $148 million.

Affinia Therapeutics, a gene therapy company with a pipeline of adeno-associated virus (AAV) gene therapies for devastating ...